Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-009324
Filing Date
2022-02-25
Accepted
2022-02-25 07:37:32
Documents
12
Period of Report
2022-02-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea156188-6k_immuronlimited.htm 6-K 13191
2 HALF YEARLY REPORT AND ACCOUNTS ea156188ex99-1_immuronlim.htm EX-99.1 444944
3 GRAPHIC image_001.jpg GRAPHIC 1395
4 GRAPHIC ex99-1_001.jpg GRAPHIC 151383
5 GRAPHIC ex99-1_002.jpg GRAPHIC 163834
6 GRAPHIC ex99-1_003.jpg GRAPHIC 2589
7 GRAPHIC ex99-1_004.jpg GRAPHIC 164632
8 GRAPHIC ex99-1_005.jpg GRAPHIC 184806
9 GRAPHIC ex99-1_006.jpg GRAPHIC 153050
10 GRAPHIC ex99-1_007.jpg GRAPHIC 7313
11 GRAPHIC ex99-1_008.jpg GRAPHIC 10322
12 GRAPHIC ex99-1_009.jpg GRAPHIC 5654
  Complete submission text file 0001213900-22-009324.txt   1624465
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 22674432
SIC: 2834 Pharmaceutical Preparations